Bryan Ball - Net Worth and Insider Trading

Bryan Ball Net Worth

The estimated net worth of Bryan Ball is at least $878,600 dollars as of 2023-06-07. Bryan Ball is the Chief Quality Officer of Immunomedics Inc and owns about 10,000 shares of Immunomedics Inc (IMMU) stock worth over $878,600. Details can be seen in Bryan Ball's Latest Holdings Summary section.

Transaction Summary of Bryan Ball


Bryan Ball Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bryan Ball owns 2 companies in total, including Immunomedics Inc (IMMU) , and Intercept Pharmaceuticals Inc (ICPT) .

Click here to see the complete history of Bryan Ball’s form 4 insider trades.

Insider Ownership Summary of Bryan Ball

Ticker Comapny Transaction Date Type of Owner
IMMU Immunomedics Inc 2020-03-04 Chief Quality Officer
ICPT Intercept Pharmaceuticals Inc 2021-01-11 Chief Quality Officer

Bryan Ball Latest Holdings Summary

Bryan Ball currently owns a total of 1 stock. Bryan Ball owns 10,000 shares of Immunomedics Inc (IMMU) as of October 3, 2019, with a value of $878,600.

Latest Holdings of Bryan Ball

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMMU Immunomedics Inc 2019-10-03 10,000 87.86 878,600

Holding Weightings of Bryan Ball

Bryan Ball Form 4 Trading Tracker

According to the SEC Form 4 filings, Bryan Ball has made a total of 2 transactions in Immunomedics Inc (IMMU) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Immunomedics Inc is the acquisition of 5,000 shares on October 3, 2019, which cost Bryan Ball around $70,900.

Insider Trading History of Bryan Ball

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
Immunomedics Inc
Immunomedics Inc
Total 2
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bryan Ball Trading Performance

GuruFocus tracks the stock performance after each of Bryan Ball's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bryan Ball is 32.4%. GuruFocus also compares Bryan Ball's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bryan Ball within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bryan Ball's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bryan Ball

Average Relative Return


Average relative return per transaction

Outperforming Transactions


2 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 16.89 32.4 8.52 337.08
Relative Return to S&P 500(%) 13.82 26.19 11.25 327.13

Bryan Ball Ownership Network

Ownership Network List of Bryan Ball

No Data

Ownership Network Relation of Bryan Ball

Bryan Ball Owned Company Details

What does Immunomedics Inc do?

Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's pipeline includes products targeting solid tumors and hematologic malignancies, among other diseases in clinical and preclinical development. The company is marketing specific diagnostic imaging agents to detect bone infections in Europe, Canada, and Australia. The company has subsidiaries in the Netherlands and Germany to manage sales and clinical trials in Europe.

Who are the key executives at Immunomedics Inc?

Bryan Ball is the Chief Quality Officer of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .

Immunomedics Inc (IMMU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.


Immunomedics Inc Insider Transactions

No Available Data

Bryan Ball Mailing Address

Above is the net worth, insider trading, and ownership report for Bryan Ball. You might contact Bryan Ball via mailing address: 300 The American Road, Morris Plains Nj 07950.